Regulatory Story
Go to market news section View chart   Print
RNS
Assura PLC  -  AGR   

Notice of Dividend

Released 14:28 08-Mar-2018

RNS Number : 1642H
Assura PLC
08 March 2018
 

 

8 March 2018

 

Assura plc

 

Notice of Dividend

 

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that the next quarterly interim dividend of 0.655 pence per share will be paid on 18 April 2018 to shareholders on the register on 16 March 2018 (the "Record Date"). The Ex-dividend Date will be 15 March 2018.

 

This interim dividend will be a normal dividend (Non-PID). Please refer to Company's website HERE for more information.

 

Shareholders may choose for the dividend to be paid either as cash or to be settled in New Shares via the Scrip Dividend Alternative. The Scrip Dividend Alternative price is to be calculated using the average of the middle market quotations for an Ordinary Share, as derived from the Daily Official List of the London Stock Exchange, for the five consecutive business days commencing on the Ex-dividend Date and will be announced by the Company and detailed on the Company's website on 22 March 2018.

 

Any shareholders wishing to take up the Scrip Dividend Alternative, who have not already done so, will have until 4.30pm on 4 April 2018 either to return their completed mandate form to the Company registrars, Link Asset Services at The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU (in the case of shareholdings in certificated form) or to take the necessary action via the CREST system (in the case of shareholdings in uncertificated form).

 

The Circular concerning this Scrip Dividend Alternative is available on the Company's website, www.assuraplc.com and is also available for inspection at the National Storage Mechanism http://www.morningstar.co.uk/uk/NSM. 

 

- Ends -

 

For more information, please contact:

 

Assura plc

 

Tel: 01925 420660

Orla Ball

 


 

Edelman

John Kiely

 

 

Tel: 0203 047 2546

Mav Wynn


Rob Yates

 


 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 30 September 2017, Assura's property portfolio was valued at £1.56 billion.

 

 

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUMPWUPRGCR
Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


Notice of Dividend - RNS